Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(+)-α-methylphenylethylamine
Dextroamphetamine sulfate
Dextroamphetamine adipate
Dextroamphetamine saccharate
Dexamphetamine
Desamfetamina
Dexamfetamina
Dexamfetamine
(S)-1-phenyl-2-propylamine
(S)-(+)-amphetamine
(+)-amphetamine
d-amphetamine
Dexamfetaminum
(+)-α-methylphenethylamine
Dexanfetamina
(αS)-α-methylbenzeneethanamine
(S)-(+)-β-phenylisopropylamine
(S)-α-methylbenzeneethanamine
(S)-amphetamine
(+)-(S)-amphetamine
Dextroamphetamine
(S)-1-phenyl-2-aminopropane
Brand Names
Zenzedi
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate
Dextroamphetamine
PMS-dextroamphetamine
Dexedrine
Adderall XR
Mixed Salts of a Single-Entity Amphetamine Product
Dextrostat
Procentra
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Adderall
Mixed Salts of a Single Entity Amphetamine Product XR
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
